Cover Image
Annual Information Service

Vitamin China E-News 1810

Published by CCM Data & Business Intelligence Product code 607204
Published 12 issues / year Content info 21 Pages
Price
Back to Top
Vitamin China E-News 1810
Published: 12 issues / year Content info: 21 Pages
Description

Welcome to the Oct. Issue of Vitamins China E-News.

This newsletter will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamin industry chain, from raw materials to end consumption. It includes breaking news from China and abroad, the latest market data (price, import & export, production, consumption, operating rates, etc.), in-depth analysis of market trends, and expert commentary from industry insiders.

Here is the Editor's Note for you to know about the Oct. issue specifically:

In Oct., prices varied from vitamin to vitamin. VA prices continued decreasing. Lonza Group announced that its VB3 factory in China's Guangdong Province will suspend production in Dec. and Zhejiang NHU has suspended providing quotations for VD3; however, both the aforementioned two products failed to have great increases in prices. VB4 prices were high because of high prices of raw materials, including liquid chlorine, hydrochloric acid, and trimethylamine.

New production lines will be seen in multiple vitamins, namely VC, VD3, D-calcium pantothenate, VB6, and folic acid. Anhui Tianyin is planning to build production lines for stable VC; Hubei Chuwei, as a new market player, will build a D-calcium pantothenate, VB6, and folic acid project; Pingdingshan Huixinyuan will soon start the construction of its 190 t/a VD3 project.

Multiple vitamin producers released their Q3 financial reports, and they are North China Pharmaceutical, Garden Biochemical, Guanfu, Zhejiang Medicine, and Kingdomway. All of these companies had YoY increases in both revenue and net profit. Notably, Garden Biochemical's shares fell until the suspension of trading. Guangji Pharmaceutical predicts a smaller net profit in Q3.

Some changes were also witnessed in the vitamin energy drink and the healthcare markets. Red Bull China's business license has expired in China, whether it will withdraw from the Chinese market has aroused much attention. Longevity Valley has extended its business to vitamin healthcare products; Australian healthcare producer Star Combo has had its offline distributor in China.

Vitamins China E-News is a monthly published newsletter, which can be downloaded in PDF format. The subscription mode for this newsletter is yearly and the subscriber will receive 12 issues per year.

Table of Contents

Table of Contents

Headline

Editor's Note

Column 1 Governmental Direction

  • Interpretation on air pollution treatment plan for Beijing-Tianjin-Hebei region and nearby areas

Column 2 Market Dynamics

  • Red Bull China sees expiration of business license
  • Multiple vitamin producers unveil their Q3 financial reports

Column 3 Company Developments

  • Update on Zhejiang NHU's Suihua Biological Fermentation Base
  • Hubei Chuwei to build D-calcium pantothenate, VB6, and folic acid project
  • On Garden Biochemical's crash of share prices
  • Kingvit Pharmaceutical's VB12 production facilities to be relocated

Column 4 Import and Export Analysis

  • Guangji Pharmaceutical predicts reduced net profit in Q3

Column 5 Price Update

  • Ex-works prices of selected vitamins in China, Oct. 2018
  • Lonza Group's plan to suspend production fails to benefit VB3 market
  • Choline chloride prices supported by high raw material prices
  • News in Brief
  • Anhui Tianyin has its stable VC derivative upgrading project's EIA results published
  • Pingdingshan Huixinyuan publishes EIA results of new VD3 project
  • Zhejiang NHU suspends quotations for VD3
  • Longevity Valley expands business into VC sector
  • Northeast Pharmaceutical predicts YoY increase in net profit in first three quarters
  • Guangji Pharmaceutical forecasts great increase in net profit during Q1-Q3
  • Kit to rapidly test vitamins developed in China
  • Zhejiang Medicine's 'Zero Direct Discharge of Wastewater' accepted
  • Australian healthcare producer Star Combo has offline distributor in China
  • US FDA amending regulations for 25-hydroxyvitamin D3 used in animal feed and drinking water
Back to Top